Objective
To provide Shareholders with capital growth and income over the long term, through investment in listed or quoted global healthcare companies.
Launch date
02/12/2016
Domicile
United Kingdom
Fund manager
Paul Major, Brett Darke
Dividend frequency
Semi-Annually
Wind-up provisions
There are no specific provisions for the termination of the life of the Company.
Market Cap (m) Total assets (m) Price (last close) NAV Discount / premium (%) Gearing (%) Dividend yield (%) Dividend dates Ongoing charge (%)
363.61 391.51 147.40 158.71 -7.13 0 3.42 Feb, Jul 1.02 (30/11/2023)
Scroll

Dividends

Dividends declared in last 12 months

Ex-dividend date Payment date Dividend amount Special dividend Financial year
01/08/2024 29/08/2024 2.520 No 2024
09/05/2024 31/05/2024 2.995 No 2023
Scroll

Performance (%)

Return type 1 year 3 years 5 years 10 years
Bellevue Healthcare Trust Share price total return 1.6 -3.2 15.7 N/A
Biotechnology & Healthcare AIC sector Share price total return 1.6 -2.4 -7.9 69.6
Scroll

Share structure

Number of shares
246,679,314

Traded volumes (number of shares)

  Yesterday 1 month 1 year 5 years
Total 5,107,802 33,710,044 402,439,116 1,486,089,684
Average N/A 1,638,650 1,600,300 1,181,350
Scroll

Traded values (m)

  Yesterday 1 month 1 year 5 years
Total 7.53 49.35 584.59 2,377.60
Average N/A 2.40 2.32 1.89
Scroll

Trading details

ISIN TIDM Traded currency Stock exchange
GB00BZCNLL95 BBH GBX London Stock Exchange - MAIN
Chi-x Europe Limited
London Stock Exchange
Scroll

Top holdings

Data as at : 31/07/2024

Investment % of total assets
CareDx Inc 7.6
Tandem Diabetes Care Inc 6.6
UnitedHealth Group Inc 6.4
Bio-Rad Laboratories Inc Class A 5.7
Charles River Laboratories International Inc 5.4
Evolent Health Inc Class A 5.3
Axsome Therapeutics Inc 5.2
Exact Sciences Corp 5.0
Option Care Health Inc 5.0
Insmed Inc 4.7

Morningstar logo Data provided by Morningstar.

FE fundinfo logo Company documents provided by FE fundinfo.